ENT Devices Market worth $22.3 billion by 2026 - Exclusive Report by MarketsandMarkets™
/PRNewswire/ -- According to the new market research report "ENT Devices Market by product (Diagnostic (Endoscope, Hearing Screening Devices), Surgical...
Stay updated with breaking news from Cochlear Limited. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- According to the new market research report "ENT Devices Market by product (Diagnostic (Endoscope, Hearing Screening Devices), Surgical...
CHICAGO, June 11, 2021 /PRNewswire/ -- According to the new market research report "ENT Devices Market by product (Diagnostic (Endoscope, Hearing Screening Devices), Surgical Devices, (Powered
Request Download Sample Ask For Discount Company Profile The latest report published by Verified Market Reports examines various factors such as
CSL Limited (ASX:CSL) and these ASX blue chip shares have been rated as buys by analysts. Here's what you need to know...
BONEBRIDGE (MED-EL), Ponto 4 (Oticon Medical), Esteem® osseointegrated active middle ear implant (AMEI) (Envoy Medical), Venus Cochlear implant system (Nurotron Biotechnology) are some of the Age-related Hearing Loss devices available in the market. Most of these available devices are FDA-approved and are CE marked. Certain emerging devices/therapeutics in the Age-related Hearing Loss market comprise the Acclaim® Cochlear Implant FX-322 (Frequency Therapeutics), among others. On June 29, 2020, Acclaim® cochlear implant was granted the Breakthrough Device Designation from the FDA. In M...